Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

5
Marijuana Company of America and Global Hemp Group Provide Update on New Brunswick Hemp Project

2018-05-22 globenewswire
ESCONDIDO, Calif., May 22, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company”) (OTC:MCOA), an innovative hemp and cannabis corporation, is pleased to provide an update on its New Brunswick Hemp Project with joint venture partner, Global Hemp Group Inc. (CSE:GHG) (OTC:GBHPF) (FRANKFURT:GHG) (the “Partners”).
GBHPF GHG MCOA

5
Global Hemp Group and Marijuana Company of America Provide an Update on Operations for Their Joint Venture CBD Hemp Farm in Scio, Oregon

2018-05-15 globenewswire
VANCOUVER, British Columbia, May 15, 2018 (GLOBE NEWSWIRE) -- via NetworkWire -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE:GHG) (OTC:GBHPF) (FRANKFURT:GHG) and joint venture partner Marijuana Company of America, Inc. (OTC:MCOA) (the “Partners”) are pleased to provide an update on their CBD hemp farming project in Scio, Oregon (the “Project”).
GBHPF GHG MCOA

5
Global Hemp Group and Marijuana Company of America Form Joint Venture to Cultivate High Yielding CBD Hemp in Scio, Oregon

2018-05-09 globenewswire
VANCOUVER, B.C., May 09, 2018 (GLOBE NEWSWIRE) -- via NetworkWire -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE:GHG) (OTC:GBHPF) (FRANKFURT:GHG) is pleased to announce that is has signed a Joint Venture Agreement (the “Agreement”) with MARIJUANA COMPANY OF AMERICA, INC. (OTC:MCOA) to cultivate high yielding CBD hemp at its recently acquired 109 acre farm (see news release of May 1, 2018) in Scio, Oregon (the “Project”).
GBHPF GHG MCOA

5
Marijuana Company of America and Global Hemp Group Form Joint Venture to Cultivate High Yielding CBD Hemp in Scio, Oregon

2018-05-09 globenewswire
ESCONDIDO, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – MARIJUANA COMPANY OF AMERICA, INC. (“MCOA” or the “Company”) (OTC:MCOA), an innovative hemp and cannabis corporation, is pleased to announce that it has signed a Joint Venture Agreement (the “Agreement”) with GLOBAL HEMP GROUP INC. (“GHG”) (CSE:GHG) (OTC:GBHPF) (FRANKFURT:GHG) to cultivate legal high yielding CBD from industrial hemp at its recently acquired 109 acre farm (see news release of May 1, 2018) in Scio, Oregon.
GBHPF GHG MCOA

2
Marijuana Company of America’s hempSMART™ Brand Engages Kim Castle and Verve Integrative to Manage Television Ad Campaign for Its CBD Product Line

2018-05-04 globenewswire
ESCONDIDO, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company”) (OTC:MCOA), an innovative hemp and cannabis corporation, is pleased to announce that its wholly owned subsidiary, H Smart, Inc. has engaged Kim Castle of Verve Integrative to create a market strategy and manage a direct response television (DRTV) ad campaign to promote its hempSMART™ product line.
MCOA

5
Marijuana Company of America and Global Hemp Group Announce Acquisition of 109 Acres of Prime Agricultural Property for Hemp CBD Production in Oregon

2018-05-01 globenewswire
ESCONDIDO, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – MARIJUANA COMPANY OF AMERICA, INC. (“MCOA” or the “Company”) (OTC:MCOA) is pleased to announce that the Company, in partnership with Global Hemp Group Inc. (CSE:GHG) (OTC:GBHPF) (FRANKFURT:GHG) has acquired a 109-acre agricultural property in Scio, Oregon (the “Property”) for the cultivation of high CBD yielding hemp for the upcoming 2018 growing season.
GBHPF GHG MCOA

5
Global Hemp Group and Marijuana Company of America Announce Acquisition of 109 Acres of Prime Agricultural Property for Hemp CBD Production in the State of Oregon

2018-05-01 globenewswire
VANCOUVER, British Columbia, May 01, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE:GHG) (OTC:GBHPF) (FRANKFURT:GHG) is pleased to announce that the Company, in partnership with Marijuana Company of America, Inc. (OTC:MCOA) has acquired a 109 acre agricultural property in Scio, Oregon (the “Property”) for the cultivation of high CBD yielding hemp for the upcoming 2018 growing season.
GBHPF GHG MCOA

2
Marijuana Company of America’s Joint Venture Completes Set-Up of 7,000 sq. ft. Greenhouse Facility in Washington State

2018-04-18 globenewswire
ESCONDIDO, Calif., April 18, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company”) (OTC:MCOA), an innovative hemp and cannabis corporation, is pleased to announce that its joint venture project, BV-MCOA Management, LLC, has completed the construction of three greenhouses totaling 7,000 square feet. This represents the completion of more than 23% of the total 30,000-square-foot cultivation facility.
MCOA

2
Marijuana Company of America Engages Eddy Pham & Company to Launch Comprehensive hempSMART™ CBD Retail Marketing Campaign

2018-03-27 globenewswire
ESCONDIDO, Calif., March 27, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company”) (OTC:MCOA), an innovative hemp and cannabis company, is pleased to announce that it has engaged Eddy Pham & Company (EPCO) to provide retail marketing and advertising services for its hempSMART™ branded products.
MCOA

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 56782E105